DexCom, Inc. (DXCM)
DexCom, Inc. (DXCM) Research & Development Expenses
The r&d expense for DexCom, Inc. (DXCM) is $594.90 Million with a year-over-year change of +7.69%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
DXCM R&D Expense Chart
DXCM R&D Expense
$594.90M+2122.30% 20Y
Zoom
Current R&D Expense
$594.90M
$594.90 Million
Year-over-Year Change
+7.69%
vs. $552.40M prior year
Historical Data
26
Years of data available
Annual R&D Expense History
| Year | R&D Expense | YoY Change | % Change |
|---|---|---|---|
| 2025 | $594.90M | +$42.50M | +7.69% |
| 2024 | $552.40M | +$46.60M | +9.21% |
| 2023 | $505.80M | +$21.60M | +4.46% |
| 2022 | $484.20M | $-120.00M | -19.86% |
| 2021 | $604.20M | +$244.30M | +67.88% |
| 2020 | $359.90M | +$86.40M | +31.59% |
| 2019 | $273.50M | $-143.90M | -34.48% |
| 2018 | $417.40M | +$232.00M | +125.13% |
| 2017 | $185.40M | +$29.30M | +18.77% |
| 2016 | $156.10M | +$18.60M | +13.53% |
| 2015 | $137.50M | +$68.10M | +98.13% |
| 2014 | $69.40M | +$24.60M | +54.91% |
| 2013 | $44.80M | +$5.30M | +13.42% |
| 2012 | $39.50M | +$8.75M | +28.47% |
| 2011 | $30.75M | +$7.52M | +32.38% |
| 2010 | $23.23M | +$8.93M | +62.49% |
| 2009 | $14.29M | $-5.33M | -27.18% |
| 2008 | $19.63M | +$3.50M | +21.68% |
| 2007 | $16.13M | $-3.29M | -16.93% |
| 2006 | $19.42M | $-7.35M | -27.46% |
| 2005 | $26.77M | +$14.30M | +114.67% |
| 2004 | $12.47M | +$3.54M | +39.57% |
| 2003 | $8.93M | +$2.62M | +41.57% |
| 2002 | $6.31M | +$1.27M | +25.24% |
| 2001 | $5.04M | +$2.14M | +73.64% |
| 2000 | $2.90M | — | — |
Data as of Wednesday, June 10, 2026